← Back to Screener
Intuitive Surgical Inc. (ISRG)
Price$412.26
Value ScoreD
Growth ScoreB
Momentum ScoreD
Favorite Metrics
Price vs S&P 500 (26W)-39.03%
Price vs S&P 500 (4W)-12.21%
VGM Score42.62
Market Capitalization$148.80B
P/E Ratio (Annual)52.10x
All Metrics
P/CF (Annual)49.10x
Book Value / Share (Quarterly)$49.31
P/TBV (Annual)11.28x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)17.39%
Cash Flow / Share (Quarterly)$7.94
Price vs S&P 500 (YTD)-35.96%
Gross Margin (TTM)66.29%
Net Profit Margin (TTM)28.15%
EPS (TTM)$8.24
10-Day Avg Trading Volume2.36M
EPS Excl Extra (TTM)$8.24
Revenue Growth (5Y)18.22%
EPS (Annual)$7.87
ROI (Annual)16.02%
Gross Margin (Annual)66.00%
Net Profit Margin (5Y Avg)26.51%
Cash / Share (Quarterly)$13.07
P/E Basic Excl Extra (TTM)49.95x
Revenue Growth QoQ (YoY)22.96%
EPS Growth (5Y)21.79%
P/E Normalized (Annual)52.10x
ROA (Last FY)13.96%
Revenue Growth TTM (YoY)21.43%
EBITD / Share (TTM)$9.35
ROE (5Y Avg)13.99%
Operating Margin (TTM)30.45%
Cash Flow / Share (Annual)$7.01
P/B Ratio8.52x
P/B Ratio (Quarterly)9.37x
Net Income / Employee (Annual)$167,800
EV / Revenue (TTM)13.87x
ROA (TTM)14.88%
EPS Growth QoQ (YoY)19.20%
EV / EBITDA (TTM)43.43x
EPS Incl Extra (Annual)$7.87
Current Ratio (Annual)4.87x
Quick Ratio (Quarterly)3.28x
3-Month Avg Trading Volume2.07M
52-Week Price Return-23.59%
EV / Free Cash Flow (Annual)58.94x
P/E Incl Extra (TTM)49.95x
Revenue / Employee (TTM)$621,700
Tangible BV / Share (Quarterly)$48.82
P/S Ratio (Annual)14.78x
Asset Turnover (Annual)0.49x
52-Week High$603.88
Operating Margin (5Y Avg)27.89%
EPS Excl Extra (Annual)$7.87
CapEx CAGR (5Y)9.59%
Tangible BV CAGR (5Y)13.03%
26-Week Price Return-23.10%
Quick Ratio (Annual)3.79x
13-Week Price Return-16.22%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)4.61x
Enterprise Value$146.79B
Revenue / Share Growth (5Y)18.10%
Asset Turnover (TTM)0.53x
Book Value / Share Growth (5Y)12.74%
Revenue / Employee (Annual)$591,300
Inventory Turnover (Annual)2.06x
Pretax Margin (Annual)32.90%
Cash / Share (Annual)$17.03
3-Month Return Std Dev31.67%
Gross Margin (5Y Avg)67.32%
Net Income / Employee (TTM)$175,000
EBITDA CAGR (5Y)18.21%
EBITDA Interim CAGR (5Y)15.37%
ROE (Last FY)16.02%
EPS Basic Excl Extra (Annual)$7.87
P/FCF (TTM)52.89x
Receivables Turnover (TTM)7.51x
EV / Free Cash Flow (TTM)52.18x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$8.24
Receivables Turnover (Annual)7.31x
ROI (TTM)16.98%
P/S Ratio (TTM)14.06x
Pretax Margin (5Y Avg)30.27%
Revenue / Share (Annual)$27.75
Tangible BV / Share (Annual)$50.15
Forward P/E38.65x
Free OCF CAGR (5Y)16.85%
Price vs S&P 500 (52W)-51.80%
P/E Ratio (TTM)49.95x
EPS Growth TTM (YoY)20.92%
Year-to-Date Return-25.02%
5-Day Price Return-3.07%
EPS Normalized (Annual)$7.87
ROA (5Y Avg)12.15%
Net Profit Margin (Annual)28.38%
Month-to-Date Return-7.20%
Cash Flow / Share (TTM)$5.54
EBITD / Share (Annual)$8.12
EPS Growth (3Y)29.18%
Operating Margin (Annual)29.27%
LT Debt / Equity (Annual)0.00x
P/CF (TTM)44.55x
ROI (5Y Avg)13.99%
P/E Excl Extra (TTM)49.95x
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$8.24
P/TBV (Quarterly)9.46x
P/B Ratio (Annual)11.26x
Inventory Turnover (TTM)2.04x
Pretax Margin (TTM)33.86%
Book Value / Share (Annual)$50.19
Price vs S&P 500 (13W)-25.97%
Net Margin Growth (5Y)3.13%
Beta1.46x
P/FCF (Annual)59.74x
Revenue / Share (TTM)$29.41
ROE (TTM)16.98%
52-Week Low$414.30
vGradeD
gGradeB
mGradeD
vgmGradeC
Show chart for
Earnings Surprise History
Q1 262.50est. 2.14
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
3.90
3.90
3.95
3.95
Industry Peers — Orthopedic & Prosthetic Devices(33)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
ISRGIntuitive Surgical Inc. | D | B | D | $412.26 |
| EWEdwards Lifesciences Corp | D | C | C | $88.16 |
| STESTERIS plc | C | B | D | $211.07 |
| ZBHZimmer Biomet Holdings, Inc. | B | C | D | $82.94 |
| ALGNAlign Technology Inc | C | C | C | $169.77 |
| SNNSmith & Nephew plc | B | C | C | $29.48 |
| MSAMine Safety Incorporated | C | C | C | $163.13 |
| ESTAEstablishment Labs Holdings Inc. | F | A | B | $68.08 |
| CDRECadre Holdings, Inc. | C | C | D | $30.62 |
| ENOVEnovis Corporation | B | D | D | $21.70 |
| AVNSAvanos Medical, Inc. | B | D | A | $25.05 |
About
Intuitive develops and commercializes robotic systems for minimally invasive surgery, along with associated instrumentation, disposable accessories, and support services. The company has deployed over 10,000 da Vinci systems globally, with more than 6,000 installed in the United States and expanding penetration in emerging markets. This installed base generates recurring revenue through consumables and service contracts while positioning Intuitive as a market leader in surgical robotics.